Lincoln Pharmaceuticals Declares 18 Final Dividend Reports Q4 Net Profit of 1163 Crore
Rajnath Singh Highlights Strategic Autonomy and Rising Private Sector Role in Indias Defence Sector
Diodes Inc CEO Gary Yu Sells 399810 in Stock Insider Transaction Highlights
Media Frenzy Over Death of Model Twisha Sharma Highlights Challenges in HighProfile Cases
Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Highs AI Stocks Enter Buy Zones
Wendy Liu Warns Against AI Dependency Preserving Human Thinking in an Era of Big Techs Privatised Intelligence
ASND Q1 2026 Earnings Miss on EPS Amid Ongoing Investment Cycle
HTH Q1 2026 Earnings Strong EPS Beat Amid Lower Stock Reaction
MG Q1 2026 Earnings EPS Beats Estimates by 553 as Company Reports Profitability
Penumbra Q1 2026 Earnings EPS Misses Estimates by 245 Amidst Operational Headwinds
Veris Residential Inc Q4 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress
SRAD Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly
Inflection Point Acquisition Corp V Units IPEXU Holds Steady at 1099 SPAC Units in Consolidation Mode
Coherus Oncology Inc CHRS Rises 255 Key Levels to Watch After Support Hold
AudioCodes Ltd AUDC Surges Over 4 as Stock Approaches Key Resistance
BranchOut Food Inc BOF Slides 217 Support Test Looms
ONE Gas Inc OGS Edges Lower Amid Consolidation Testing NearTerm Support
Silicon Valley Turns to Boring Businesses AI and Dealmaking Reshape Unsexy Industries
PMTW Q1 2026 Earnings EPS Misses Estimates Amid Challenging Mortgage Market
Rave Restaurant Group RAVE Slips 236 as Stock Tests Support Near 275
CNTN Q4 2023 Earnings Significant Loss Beat as Strategic Initiatives Gain Traction
ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress
SRTA Q1 2026 Earnings Strong EPS Surprise Signals Turnaround Momentum
ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase
PAC Q1 2026 Earnings Strong EPS Beat Fails to Lift Stock Amid Cautious Sentiment
CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses
CMCSA Q1 2026 Earnings EPS Beats Estimates Amid Mixed Signals